Biomedicine. Do G quartets orchestrate fragile X pathology?
Moine
H
H
UPR9002 CNRS, 67084 Strasbourg Cedex, France.
Mandel
J L
JL
D000818:Animals; D001665:Binding Sites; D001921:Brain / Q000378:metabolism; D018360:Crystallography, X-Ray; D051860:Fragile X Messenger Ribonucleoprotein 1; D005600:Fragile X Syndrome / Q000235:genetics / Q000378:metabolism*; D005786:Gene Expression Regulation; D006801:Humans; D051379:Mice; D009419:Nerve Tissue Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D009690:Nucleic Acid Conformation; D020411:Oligonucleotide Array Sequence Analysis; D014176:Protein Biosynthesis; D017434:Protein Structure, Tertiary; D012333:RNA, Messenger / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D016601:RNA-Binding Proteins; D013569:Synapses / Q000502:physiology; D020506:Untranslated Regions
D051860:Fragile X Messenger Ribonucleoprotein 1; D009419:Nerve Tissue Proteins; D012333:RNA, Messenger; D016601:RNA-Binding Proteins; D020506:Untranslated Regions; C497683:FMR1 protein, human; C497684:Fmr1 protein, mouse